Weight reduction achieved through these agents facilitates management of other diabetes co-morbidities and reduces cardiovascular complications
Isolation of neonatal extrahepatic cholangiocytes
Humira (Adalimumab) Humira 2023 Sales: $14.404 billion Company/Developer: AbbVie Date of First FDA Approval: December 31, 2002 Indications Humira Is FDA-Approved for: Rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohns disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis Cost of Humira: The price of two Humira subcutaneous kits (40 mg/0.4 mL each) is around $7,299
The EVEXIAS line is exclusively available through your healthcare provider
If your Mochi vial contains additives, the vial label will list them